ALS Investment Fund

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

Bloom Science is a clinical-stage central nervous system company developing novel therapeutics for patients with neurological disorders.

Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.